Search results
Results from the WOW.Com Content Network
Potentially serious side effects are unusual, but include severe allergic reaction, eye pain or change in vision, or urinary retention. It is considered safe during pregnancy, but it can pass into breast milk and may harm a nursing baby. [11] Ipratropium bromide was patented in 1966, and approved for medical use in 1974. [12]
Important [5] muscarinic antagonists include atropine, hyoscyamine, hyoscine butylbromide and hydrobromide, ipratropium, tropicamide, cyclopentolate, pirenzepine and scopalamine. Muscarinic antagonists such as ipratropium bromide can also be effective in treating asthma , since acetylcholine is known to cause smooth muscle contraction ...
Ipratropium bromide/salbutamol, sold under the brand name Combivent among others, is a combination medication used to treat chronic obstructive pulmonary disease (COPD). [ 1 ] [ 4 ] [ 5 ] It contains ipratropium (an anticholinergic ) and salbutamol (albuterol, a β 2 -adrenergic agonist ).
with umeclidinium bromide: Anoro Ellipta. Umeclidinium bromide is a long-acting muscarinic antagonist. [14] This combination was approved by the FDA on December 18, 2013 [15] for the long-term maintenance treatment of COPD. On March 28, 2014, it was approved in European countries [16] and in Russia [17] under the same trade name.
Bromide salts are used in hot tubs as mild germicidal agents to generate in situ hypobromite. The bromide ion is antiepileptic and as bromide salt, is used in veterinary medicine in the US. The kidneys excrete bromide ions. The half-life of bromide in the human body (12 days) is long compared with many pharmaceuticals, making dosing challenging ...
The cites discuss ipratropium bromide not ipratropium; the drug itself is what is notable, not what it is composed of.1archie99 17:49, 11 February 2011 (UTC) Relisting... there seems to be a great deal of confusion as to what the exact topic of this article is or should be, Both the schematic and the systematic name given in the infobox appear ...
An inhaler (puffer, asthma pump or allergy spray) is a medical device used for delivering medicines into the lungs through the work of a person's breathing. This allows medicines to be delivered to and absorbed in the lungs, which provides the ability for targeted medical treatment to this specific region of the body, as well as a reduction in the side effects of oral medications.
Bromide has an elimination half-life of 9 to 12 days, which can lead to excessive accumulation. Doses of 0.5 to 1 gram per day of bromide can lead to bromism. Historically, the therapeutic dose of bromide is about 3 to 5 grams of bromide, thus explaining why chronic toxicity (bromism) was once so common.